top of page
Lucivande (vandetanib)

You can buy Lucivande at the lowest price in the online pharmacy Nextgen.ooo . Vandetanib is an oral once-daily kinase inhibitor of tumour angiogenesis and tumour cell proliferation with the potential for use in a broad range of tumour types. Vandetanib is currently approved as an alternative to local therapies for both unresectable and disseminated disease. Because Vandetanib can prolong the Q-T interval, it is contraindicated for use in patients with serious cardiac complications such as congenital long QT syndrome and uncompensated heart failure.

 

Vandetanib is a potent and selective inhibitor of VEGFR (vascular endothelial growth factor receptor), EGFR (epidermal growth factor receptor) and RET (REarranged during Transfection) tyrosine kinases. VEGFR- and EGFR-dependent signalling are both clinically validated pathways in cancer, including non-small-cell lung cancer (NSCLC). RET activity is important in some types of thyroid cancer, and early data with vandetanib in medullary thyroid cancer has led to orphan-drug designation by the regulatory authorities in the USA and EU.

Lucivande (vandetanib)

$930.00Price
Quantity
  • General information

    Active ingredient - Vandetanib

    Original name - Caprelsa

    Quantity in package - 30 pcs

    Dosage - 300 mg

    Storage temperature - up to 30°C

    Country of manufacture - Laos

    Manufacturer - Lucius Pharmaceuticals

No Reviews YetShare your thoughts. Be the first to leave a review.

© 2025 A limited liability company NextGen

 +85247535208 | +79804778294 | +37443459494

email for support:   support@nextgen.ooo 

obtaining information:   info@nextgen.ooo  

The site is for informational purposes only and is not a public offer. All information is posted for informational purposes and cannot be used for self-medication; treatment can only be prescribed by a competent specialist. The site provides consultations on the delivery of drugs from China, India, Bangladesh and Laos and does not sell drugs in the recipient country.

bottom of page